Works by Takeuchi, Hiroto


Results: 14
    1

    Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.

    Published in:
    Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1570717
    By:
    • Maekawa, Naoya;
    • Konnai, Satoru;
    • Watari, Kei;
    • Takeuchi, Hiroto;
    • Nakanishi, Takeshi;
    • Tachibana, Taro;
    • Hosoya, Kenji;
    • Kim, Sangho;
    • Kinoshita, Ryohei;
    • Owaki, Ryo;
    • Yokokawa, Madoka;
    • Kagawa, Yumiko;
    • Takagi, Satoshi;
    • Deguchi, Tatsuya;
    • Ohta, Hiroshi;
    • Kato, Yukinari;
    • Yamamoto, Satoshi;
    • Yamamoto, Keiichi;
    • Suzuki, Yasuhiko;
    • Okagawa, Tomohiro
    Publication type:
    Article
    2
    3
    4

    Exploration of serum biomarkers in dogs with malignant melanoma receiving anti-PD-L1 therapy and potential of COX-2 inhibition for combination therapy.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13484-8
    By:
    • Maekawa, Naoya;
    • Konnai, Satoru;
    • Asano, Yumie;
    • Sajiki, Yamato;
    • Deguchi, Tatsuya;
    • Okagawa, Tomohiro;
    • Watari, Kei;
    • Takeuchi, Hiroto;
    • Takagi, Satoshi;
    • Hosoya, Kenji;
    • Kim, Sangho;
    • Ohta, Hiroshi;
    • Kato, Yukinari;
    • Suzuki, Yasuhiko;
    • Murata, Shiro;
    • Ohashi, Kazuhiko
    Publication type:
    Article
    5
    6
    7
    8
    9

    Enhanced Systemic Antitumour Immunity by Hypofractionated Radiotherapy and Anti-PD-L1 Therapy in Dogs with Pulmonary Metastatic Oral Malignant Melanoma.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 3013, doi. 10.3390/cancers15113013
    By:
    • Deguchi, Tatsuya;
    • Maekawa, Naoya;
    • Konnai, Satoru;
    • Owaki, Ryo;
    • Hosoya, Kenji;
    • Morishita, Keitaro;
    • Nakamura, Motoji;
    • Okagawa, Tomohiro;
    • Takeuchi, Hiroto;
    • Kim, Sangho;
    • Kinoshita, Ryohei;
    • Tachibana, Yurika;
    • Yokokawa, Madoka;
    • Takagi, Satoshi;
    • Kato, Yukinari;
    • Suzuki, Yasuhiko;
    • Murata, Shiro;
    • Ohashi, Kazuhiko
    Publication type:
    Article
    10

    Safety and clinical efficacy of an anti-PD-L1 antibody (c4G12) in dogs with advanced malignant tumours.

    Published in:
    PLoS ONE, 2023, v. 18, n. 10, p. 1, doi. 10.1371/journal.pone.0291727
    By:
    • Maekawa, Naoya;
    • Konnai, Satoru;
    • Hosoya, Kenji;
    • Kim, Sangho;
    • Kinoshita, Ryohei;
    • Deguchi, Tatsuya;
    • Owaki, Ryo;
    • Tachibana, Yurika;
    • Yokokawa, Madoka;
    • Takeuchi, Hiroto;
    • Kagawa, Yumiko;
    • Takagi, Satoshi;
    • Ohta, Hiroshi;
    • Kato, Yukinari;
    • Yamamoto, Satoshi;
    • Yamamoto, Keiichi;
    • Suzuki, Yasuhiko;
    • Okagawa, Tomohiro;
    • Murata, Shiro;
    • Ohashi, Kazuhiko
    Publication type:
    Article
    11
    12

    Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumors.

    Published in:
    PLoS ONE, 2023, v. 18, n. 1, p. 1, doi. 10.1371/journal.pone.0281143
    By:
    • Maekawa, Naoya;
    • Konnai, Satoru;
    • Asano, Yumie;
    • Otsuka, Takumi;
    • Aoki, Eri;
    • Takeuchi, Hiroto;
    • Kato, Yukinari;
    • Kaneko, Mika K.;
    • Yamada, Shinji;
    • Kagawa, Yumiko;
    • Nishimura, Maki;
    • Takagi, Satoshi;
    • Deguchi, Tatsuya;
    • Ohta, Hiroshi;
    • Nakagawa, Takayuki;
    • Suzuki, Yasuhiko;
    • Okagawa, Tomohiro;
    • Murata, Shiro;
    • Ohashi, Kazuhiko
    Publication type:
    Article
    13
    14